2,288
Views
7
CrossRef citations to date
0
Altmetric
Editorial

The therapeutic potential of novel anti-migraine acute therapies

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Matilde Capi, Fernando de Andrés, Luana Lionetto, Giovanna Gentile, Fabiola Cipolla, Andrea Negro, Marina Borro, Paolo Martelletti & Martina Curto. (2017) Lasmiditan for the treatment of migraine. Expert Opinion on Investigational Drugs 26:2, pages 227-234.
Read now

Articles from other publishers (5)

SAMEER H. SAWANT & AYESHA MUJAWAR. (2022) ANTIMIGRAINE ACTIVITY OF METHANOLIC EXTRACT OF ABROMA AUGUSTA L. IN LABORATORY ANIMALS. International Journal of Pharmacy and Pharmaceutical Sciences, pages 54-59.
Crossref
Licia Grazzi, Cristina Tassorelli, Marina de Tommaso, Giulia Pierangeli, Paolo Martelletti, Innocenzo Rainero, Pierangelo Geppetti, Anna Ambrosini, Paola Sarchielli, Eric Liebler & Piero Barbanti. (2018) Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial. The Journal of Headache and Pain 19:1.
Crossref
Giannapia Affaitati, Paolo Martelletti, Mariangela Lopopolo, Claudio Tana, Francesca Massimini, Francesco Cipollone, Domenico Lapenna, Maria Adele Giamberardino & Raffaele Costantini. (2017) Use of Nonsteroidal Anti-Inflammatory Drugs for Symptomatic Treatment of Episodic Headache. Pain Practice 17:3, pages 392-401.
Crossref
Fabio Antonaci, Natascia Ghiotto, Shizheng Wu, Ennio Pucci & Alfredo Costa. (2016) Recent advances in migraine therapy. SpringerPlus 5:1.
Crossref
Maria Adele Giamberardino, Giannapia Affaitati, Martina Curto, Andrea Negro, Raffaele Costantini & Paolo Martelletti. (2016) Anti-CGRP monoclonal antibodies in migraine: current perspectives. Internal and Emergency Medicine 11:8, pages 1045-1057.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.